Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C38 - The Dystonias: Diagnosis, Treatment, and Update on Etiologies

Sunday 04/14/24
07:00 AM - 09:00 AM MDT Add To Calendar
Colorado Convention Center | Four Seasons 4
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Ian O. Bledsoe, MD
Movement Disorders
Participants should gain familiarity with the clinical features and phenomenology of dystonia; dystonia classification and differential diagnosis; the most common genetic forms of dystonia, recent genetic etiologies, and basis for clinical genetic testing in dystonia; and principles of treatment of dystonia with oral medications, botulinum toxin, rehabilitation, and surgical treatments including deep brain stimulation.
 
This program is supported in part by an educational grant from Merz Pharmaceuticals, LLC and Ipsen Biopharmaceuticals, Inc.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:10 AM MDT Introduction Introduction
Ian O. Bledsoe, MD, Christopher D. Stephen, MB ChB FRCP SM
07:10 AM - 08:00 AM MDT Speaker Dystonia Diagnosis, Phenomenology, and Etiology
Christopher D. Stephen, MB ChB FRCP SM
08:00 AM - 08:50 AM MDT Speaker Treatment of Dystonia
Ian O. Bledsoe, MD
08:50 AM - 09:00 AM MDT Q&A Questions & Answers
Ian O. Bledsoe, MD, Christopher D. Stephen, MB ChB FRCP SM
Faculty Disclosures
Christopher D. Stephen, MB ChB FRCP SM Dr. Stephen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Ian O. Bledsoe, MD Dr. Bledsoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Bledsoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Destum Partners. Dr. Bledsoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Inc. The institution of Dr. Bledsoe has received research support from Dystonia Medical Research Foundation. The institution of Dr. Bledsoe has received research support from NIH. The institution of Dr. Bledsoe has received research support from Michael J Fox Foundation.